Key Highlights
- Veterinary medicine is concerned with preventing, controlling, diagnosing, and treating diseases affecting the health of both food-producing and companion animals and preventing the transmission of animal diseases to humans.
- The North American veterinary medicine market recorded revenues of $14.48 billion in 2024, representing a compound annual growth rate (CAGR) of 5.7% between 2019 and 2024.
- The pharmaceutical segment accounted for the market's largest proportion in 2024, with total revenues of $8.44 billion, equivalent to 58.3% of the market's overall value.
- North America accounted for the largest share of 43.3% of the global veterinary medicine market in 2024.
Report Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the veterinary medicine market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the veterinary medicine market in North America
- Leading company profiles reveal details of key veterinary medicine market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America veterinary medicine market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the North America veterinary medicine market by value in 2024?
- What will be the size of the North America veterinary medicine market in 2029?
- What factors are affecting the strength of competition in the North America veterinary medicine market?
- How has the market performed over the last five years?
- Who are the top competitors in North America's veterinary medicine market?
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Zoetis Inc
- Merck & Co Inc
- Elanco Animal Health Inc
- Idexx Laboratories Inc
- Boehringer Ingelheim International GmbH

